Market Research Logo

Custom Antibody Market by Service (Antibody Production, Characterization, Immunization, Fragmentation), Type (Monoclonal, Polyclonal, Recombinant), Source (Mouse, Rabbit), Research Area (Oncology, Immunology), and End Users - Global Forecast to 2023

Custom Antibody Market by Service (Antibody Production, Characterization, Immunization, Fragmentation), Type (Monoclonal, Polyclonal, Recombinant), Source (Mouse, Rabbit), Research Area (Oncology, Immunology), and End Users - Global Forecast to 2023

“The global custom antibody market is projected to grow at a CAGR of 8.9%.”
The custom antibody market is expected to reach USD 481 million by 2023 from an estimated USD 313 million in 2018, at a CAGR of 8.9%. Increase in research activities (especially in the life sciences industry), growing industry-academia collaborations, and the expanding antibody therapeutics pipeline are the primary growth drivers for this market. Rapid growth in developing countries across APAC and Latin America and the increasing demand for personalized medicine and protein therapeutics are expected to offer significant growth opportunities for players in this market. However, the need for steep capital investments and long duration of antibody development, along with the increasing focus on antibody alternatives for proteomic studies, are some of the major market challenges.

“Antibody production & purification segment to grow at the highest rate during the forecast period.”
On the basis of services, the custom antibody market is segmented into antibody development, antibody production & purification, and antibody fragmentation & labeling. The antibody production & purification segment is projected to witness the highest growth in the custom antibody services market during the forecast period. Growth in this segment is largely driven by the need for high-quality antibodies for research reproducibility and generating high-quality therapeutics.

“The recombinant antibodies segment is expected to grow at the highest CAGR during the forecast period.”
Based on type, custom antibodies are categorized as monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other custom antibodies. The recombinant antibodies segment is projected to witness the highest growth rate during the forecast period. The increasing development of recombinant antibodies due to their advantages such as batch-to-batch reproducibility, rapid production along with their capability of data reproducibility within research is propelling the growth of this segment during the forecast period.

“APAC is projected to witness the highest growth during the forecast period.”
Even though North America is expected to account for the largest share of the global custom antibody market in 2018, APAC is expected to witness the highest CAGR during the forecast period. The growing Asian scientific base and capability, growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, growing awareness about personalized therapeutics, and increasing research activities in the field of mAb-based therapeutics are factors driving the growth of this regional segment.

A breakdown of the primary participants referred to for this report is provided below:
By Company Type: Tier 1–48%, Tier 2–34%, and Tier 3–18%
By Designation: C-level–42%, Director Level–40%, and Others–18%
By Region: North America–35%, Europe–25%, Asia Pacific–30%, Row – 7%

The prominent players in the global custom antibody market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck Group (Germany), Abcam plc (UK), Cell Signaling Technology, Inc. (US), Agilent Technologies, Inc. (US), GenScript (US), BioLegend, Inc. (US), Rockland Immunochemicals (US), ProMab Biotechnologies (US), Innovagen AB (Sweden), and ProteoGenix (US).

Research Coverage:
The report analyzes the market for various custom antibody services and their adoption pattern. It aims at estimating the market size and future growth potential of the global custom antibody market and different segments such as service, type, source, research area, end user, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global custom antibody market
Product & Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global custom antibody market
Market Development: Comprehensive information on the lucrative emerging regions by service, type, source, research area, end user, and region
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global custom antibody market
Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of leading players in the global custom antibody market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • STAKEHOLDERS
    • LIMITATIONS
  • RESEARCH METHODOLOGY
    • RESEARCH APPROACH
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
    • MARKET SIZE ESTIMATION
    • DATA TRIANGULATION APPROACH
    • MARKET SHARE ESTIMATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • CUSTOM ANTIBODIES: MARKET OVERVIEW
    • CUSTOM ANTIBODIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • REGIONAL MIX: CUSTOM ANTIBODIES MARKET (2018–2023)
    • CUSTOM ANTIBODIES MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2018 VS. 2023
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • MARKET DRIVERS
        • Table MARKET DRIVERS: IMPACT ANALYSIS
      • MARKET OPPORTUNITIES
        • Table MARKET OPPORTUNITIES: IMPACT ANALYSIS
      • MARKET CHALLENGES
        • Table MARKET CHALLENGES: IMPACT ANALYSIS
      • INDUSTRY TRENDS
  • CUSTOM ANTIBODY MARKET, BY SERVICE
    • INTRODUCTION
      • Table CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
    • ANTIBODY DEVELOPMENT
      • Table ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ANTIBODY DEVELOPMENT MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • ANTIBODY CHARACTERIZATION
        • Table ANTIBODY CHARACTERIZATION MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • ANTIGEN PREPARATION
        • Table ANTIGEN PREPARATION MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • IMMUNIZATION & HYBRIDOMA PRODUCTION
        • Table IMMUNIZATION & HYBRIDOMA PRODUCTION MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
    • ANTIBODY PRODUCTION & PURIFICATION
      • Table ANTIBODY PRODUCTION & PURIFICATION MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
    • ANTIBODY FRAGMENTATION & LABELING
      • Table ANTIBODY FRAGMENTATION & LABELING MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
  • CUSTOM ANTIBODY MARKET, BY TYPE
    • INTRODUCTION
      • Table CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
    • MONOCLONAL ANTIBODIES
      • MONOCLONAL ANTIBODIES TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
        • Table CUSTOM MONOCLONAL ANTIBODIES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
    • POLYCLONAL ANTIBODIES
      • POLYCLONAL ABS ARE PREFERRED IN PROTEOMIC RESEARCH FOR DETECTION OF DENATURED PROTEINS
        • Table CUSTOM POLYCLONAL ANTIBODIES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
    • RECOMBINANT ANTIBODIES
      • RESEARCH REPRODUCIBILITY OFFERED BY THESE ANTIBODIES IS DRIVING THE GROWTH OF THE RECOMBINANT ANTIBODIES SEGMENT
        • Table CUSTOM RECOMBINANT ANTIBODIES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
    • OTHER CUSTOM ANTIBODIES
      • Table OTHER CUSTOM ANTIBODIES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
  • CUSTOM ANTIBODY MARKET, BY SOURCE
    • INTRODUCTION
      • Table CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
    • MICE
      • MICE ARE THE MOST PREFERRED HOSTS FOR MONOCLONAL ANTIBODY PRODUCTION
        • Table CUSTOM ANTIBODIES MARKET FOR MICE, BY COUNTRY, 2016–2023 (USD MILLION)
    • RABBITS
      • ANTIBODIES DEVELOPED IN RABBITS ELIMINATE THE LIMITATION OF SELF-ANTIGEN RECOGNITION IN HUMANS
        • Table CUSTOM ANTIBODIES MARKET FOR RABBITS, BY COUNTRY, 2016–2023 (USD MILLION)
    • OTHER SOURCES
      • Table CUSTOM ANTIBODIES MARKET FOR OTHER SOURCES, BY COUNTRY, 2016–2023 (USD MILLION)
  • CUSTOM ANTIBODY MARKET, BY RESEARCH AREA
    • INTRODUCTION
      • Table CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
    • ONCOLOGY
      • USE OF ANTIBODIES HAS GROWN CONSIDERABLY IN CANCER RESEARCH
        • Table CUSTOM ANTIBODIES MARKET FOR ONCOLOGY, BY COUNTRY, 2016–2023 (USD MILLION)
    • INFECTIOUS DISEASES
      • ANTIBODIES ARE WIDELY USED IN R&D FOR THE DEVELOPMENT OF VACCINES & THERAPEUTICS AGAINST VARIOUS INFECTIOUS DISEASES
        • Table CUSTOM ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2016–2023 (USD MILLION)
    • IMMUNOLOGY
      • ASSESSMENT OF CELL SURFACE ANTIGENS USING ANTIBODIES FORMS AN IMPORTANT FIELD OF RESEARCH IN IMMUNOLOGY
        • Table CUSTOM ANTIBODIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2016–2023 (USD MILLION)
    • NEUROBIOLOGY
      • NEUROBIOLOGY FORMS ONE OF THE FASTEST-GROWING SEGMENTS IN TERMS OF RESEARCH BEING UNDERTAKEN UTILIZING ANTIBODIES
        • Table CUSTOM ANTIBODIES MARKET FOR NEUROBIOLOGY, BY COUNTRY, 2016–2023 (USD MILLION)
    • STEM CELLS
      • AVAILABILITY OF HIGH-QUALITY ANTIBODIES HAS BOOSTED STEM CELL RESEARCH
        • Table CUSTOM ANTIBODIES MARKET FOR STEM CELLS, BY COUNTRY, 2016–2023 (USD MILLION)
    • CARDIOVASCULAR DISEASES
      • IDENTIFICATION & CHARACTERIZATION OF CVD BIOMARKERS IS AN IMPORTANT RESEARCH AREA UTILIZING ANTIBODIES
        • Table CUSTOM ANTIBODIES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2016–2023 (USD MILLION)
    • OTHER RESEARCH AREAS
      • Table CUSTOM ANTIBODIES MARKET FOR OTHER RESEARCH AREAS, BY COUNTRY, 2016–2023 (USD MILLION)
  • CUSTOM ANTIBODY MARKET, BY END USER
    • INTRODUCTION
      • Table CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF CUSTOM ANTIBODIES
        • Table CUSTOM ANTIBODIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION)
    • ACADEMIC & RESEARCH INSTITUTES
      • INCREASE IN DNA SEQUENCING STUDIES AND PROTEOMIC RESEARCH TO DRIVE MARKET GROWTH
        • Table CUSTOM ANTIBODIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION)
    • CONTRACT RESEARCH ORGANIZATIONS
      • CROS PROVIDE AFFORDABLE OUTLETS FOR COMPANIES AND ACADEMIA TO PURSUE NEW MEDICINES AND OFFER A COSTEFFECTIVE SOLUTION TO DEVELOP DRUGS
        • Table CUSTOM ANTIBODIES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
  • CUSTOM ANTIBODY MARKET, BY REGION
    • INTRODUCTION
      • Table CUSTOM ANTIBODIES MARKET, BY REGION, 2016–2023 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: CUSTOM ANTIBODIES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
      • US
        • Table US: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table US: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table US: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table US: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table US: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table US: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
      • CANADA
        • Table CANADA: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table CANADA: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table CANADA: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table CANADA: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
    • EUROPE
      • Table EUROPE: CUSTOM ANTIBODIES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
      • Table EUROPE: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
      • Table EUROPE: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
      • Table EUROPE: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
      • GERMANY
        • Table GERMANY: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table GERMANY: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table GERMANY: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table GERMANY: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
      • UK
        • Table UK: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table UK: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table UK: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table UK: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table UK: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
      • FRANCE
        • Table FRANCE: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table FRANCE: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table FRANCE: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table FRANCE: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
      • ITALY
        • Table ITALY: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table ITALY: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ITALY: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table ITALY: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table ITALY: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
      • SPAIN
        • Table SPAIN: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table SPAIN: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table SPAIN: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table SPAIN: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table SPAIN: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table ROE: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROE: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table ROE: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table ROE: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: CUSTOM ANTIBODIES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
      • Table ASIA PACIFIC: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
      • JAPAN
        • Table JAPAN: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table JAPAN: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table JAPAN: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table JAPAN: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table JAPAN: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table JAPAN: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
      • CHINA
        • Table CHINA: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table CHINA: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CHINA: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table CHINA: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table CHINA: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table CHINA: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
      • INDIA
        • Table INDIA: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table INDIA: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table INDIA: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table INDIA: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table INDIA: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table INDIA: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table ROAPAC: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROAPAC: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table ROAPAC: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table ROAPAC: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table ROAPAC: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
    • LATIN AMERICA
      • INCREASING APPLICATIONS OF RESEARCH-SPECIFIC CUSTOM ANTIBODIES TO DRIVE THE GROWTH OF THE MARKET IN THE REGION
        • Table LATIN AMERICA: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table LATIN AMERICA: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table LATIN AMERICA: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table LATIN AMERICA: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table LATIN AMERICA: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table LATIN AMERICA: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • GROWING FOCUS OF PHARMACEUTICAL COMPANIES ON THE AFRICAN MARKET IS DRIVING THE MARKET FOR CUSTOM ANTIBODIES IN THE REGION
        • Table MIDDLE EAST & AFRICA: CUSTOM ANTIBODIES MARKET, BY SERVICE, 2016–2023 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: ANTIBODY DEVELOPMENT MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CUSTOM ANTIBODIES MARKET, BY TYPE, 2016–2023 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CUSTOM ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CUSTOM ANTIBODIES MARKET, BY RESEARCH AREA, 2016–2023 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CUSTOM ANTIBODIES MARKET, BY END USER, 2016–2023 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
      • Table CUSTOM ANTIBODIES MARKET SHARE, BY KEY PLAYER, 2017
    • COMPETITIVE SITUATION AND TRENDS
      • PRODUCT & SERVICES LAUNCHES
        • Table PRODUCT AND SERVICE LAUNCHES, 2015–2018
      • EXPANSIONS
        • Table EXPANSIONS, 2015–2018
      • ACQUISITIONS
        • Table ACQUISITIONS, 2015–2018
      • OTHER STRATEGIES
        • Table OTHER STRATEGIES, 2015–2018
  • COMPANY PROFILES
    • THERMO FISHER SCIENTIFIC INC.
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • SWOT ANALYSIS
      • MNM VIEW
    • GENSCRIPT
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • SWOT ANALYSIS
      • MNM VIEW
    • ABCAM PLC
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • SWOT ANALYSIS
      • MNM VIEW
    • MERCK GROUP
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • SWOT ANALYSIS
      • MNM VIEW
    • BIO-RAD LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • SWOT ANALYSIS
      • MNM VIEW
    • CELL SIGNALING TECHNOLOGY, INC.
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • AGILENT TECHNOLOGIES, INC.
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIOLEGEND, INC.
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ROCKLAND IMMUNOCHEMICALS INC.
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • MNM VIEW
    • PROMAB BIOTECHNOLOGIES, INC.
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • MNM VIEW
    • PROTEOGENIX
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • MNM VIEW
    • INNOVAGEN AB
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • MNM VIEW
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report